1
TÍTULO: STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
AUTORES: Peter Ferenci; Tarik Asselah; Graham R Foster; Stefan Zeuzem; Christoph Sarrazin; Christophe Moreno; Denis Ouzan; Marina Maevskaya; Filipe Calinas; Luis E Morano; Javier Crespo; Jean Francois Dufour; Marc Bourliere; Kosh Agarwal; Daniel Forton; Marcus Schuchmann; Elmar Zehnter; Shuhei Nishiguchi; Masao Omata; George Kukolj; Yakov Datsenko; Miguel Garcia; Joseph Scherer; Anne Marie Quinson; Jerry O Stern; ...Mais
PUBLICAÇÃO: 2015, FONTE: JOURNAL OF HEPATOLOGY, VOLUME: 62, NÚMERO: 6
INDEXADO EM: WOS CrossRef
2
TÍTULO: ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV
AUTORES: Peter Ferenci; David Bernstein; Jacob Lalezari; Daniel Cohen; Yan Luo; Curtis Cooper; Edward Tam; Rui T Marinho; Naoky Tsai; Anders Nyberg; Terry D Box; Ziad Younes; Pedram Enayati; Sinikka Green; Yaacov Baruch; Bal Raj Bhandari; Florin Alexandru Caruntu; Thomas Sepe; Vladimir Chulanov; Ewa Janczewska; Giuliano Rizzardini; Judit Gervain; Ramon Planas; Christophe Moreno; Tarek Hassanein; Wangang G Xie; Martin King; Thomas Podsadecki; Rajender R Reddy; ...Mais
PUBLICAÇÃO: 2014, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 370, NÚMERO: 21
INDEXADO EM: Scopus WOS CrossRef
3
TÍTULO: Time to Viral Suppression is Not Related to Achievement of SVR12 in HCV GT1-infected Patients Treated with ABT-450/r/Ombitasvir and Dasabuvir With or Without Ribavirin
AUTORES: Mark S Sulkowski; Michael W Fried; Resat Ozaras; Vasily Isakov; David L Wyles; Peter Ferenci; Jordan J Feld; Filipe Calinas; Michael Gschwantler; Martin King; Tolga Baykal; Edward J Gane;
PUBLICAÇÃO: 2014, FONTE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
INDEXADO EM: WOS
4
TÍTULO: EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON alpha-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS
AUTORES: Ferenci, P; Dieterich, D; Zeuzem, S; Mantry, P; Sarrazin, C; Crespo, J; Tam, E; Dufour, JF; Yoshida, EM; Nishiguchi, S; Bourliere, M; Omata, M; Abergel, A; Kuboki, M; Carvalho, A; Peng, CY; Romero Gomez, M; Wright, D; Stern, JO; Boecher, W; Kukolj, G; Gallivan, JP; Scherer, J; Jensen, DM; ...Mais
PUBLICAÇÃO: 2014, FONTE: 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver in JOURNAL OF HEPATOLOGY, VOLUME: 60, NÚMERO: 1
INDEXADO EM: WOS
5
TÍTULO: SIMILAR ADJUSTED SVR12 RATES FOR HIV CO-INFECTED AND HCV MONO-INFECTED PATIENTS AND NO DOSE OR POPULATION (TREATMENT-NAIVE/RELAPSER) EFFECT: POOLED ANALYSIS OF FALDAPREVIR PHASE III TRIALS
AUTORES: Dieterich, D; Ferenci, P; Jacobson, IM; Negro, F; Puoti, M; Rockstroh, JK; Manns, MP; Arasteh, K; Oliveira, C; Dufour, JF; Zehnter, E; Leen, C; Bhagani, S; Stern, JO; Quinson, AM; Scherer, J; Manero, M; Jensen, DM;
PUBLICAÇÃO: 2014, FONTE: 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver in JOURNAL OF HEPATOLOGY, VOLUME: 60, NÚMERO: 1
INDEXADO EM: WOS
6
TÍTULO: PEARL-III: 12 WEEKS OF ABT-450/R/267+ABT-333 ACHIEVED SVR IN > 99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN
AUTORES: Ferenci, P; Nyberg, A; Enayati, P; Bernstein, D; Baruch, Y; Caruntu, FA; Chulanov, V; Janczewska, E; Younes, Z; Marinho, RT; Rizzardini, G; Gervain, J; Planas, R; Moreno, C; Xie, W; Cohen, D; King, M; Podsadecki, T; Reddy, KR;
PUBLICAÇÃO: 2014, FONTE: 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver in JOURNAL OF HEPATOLOGY, VOLUME: 60, NÚMERO: 1
INDEXADO EM: WOS
7
TÍTULO: STARTVerso3: A randomized, double-blind, placebo-controlled Phase III trial of faldaprevir in combination with pegylated interferon alfa-2a and ribavirin in treatment-experienced patients with chronic hepatitis C genotype-1 infection  Full Text
AUTORES: Ira M Jacobson; Tarik Asselah; Peter Ferenci; Graham R Foster; Donald M Jensen; Francesco Negro; Parvez S Mantry; David Wright; Xavier Forns; Javier Garcia Samaniego; Celia Oliveira; Armando Carvalho; Daniel M Forton; Kosh Agarwal; Keikawus Arasteh; Curtis Cooper; Wayne Ghesquiere; Jean Francois Dufour; Yoshiyuki Sakai; Yasuhito Tanaka; Jerry O Stern; Nanshi S Sha; Wulf O Boecher; Gerhard G Steinmann; Anne Marie Quinson; ...Mais
PUBLICAÇÃO: 2013, FONTE: 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 58
INDEXADO EM: WOS